Botanical Ingredient

Antharidin Key Features:

1. Time-Tested Elixir: Antharidin Powder harnesses the power of nature’s time-tested elixir, bringing you a skincare remedy that has been trusted for generations. The therapeutic benefits of Antharidin are well-documented, making it a go-to solution for those seeking effective and natural skincare.
2. Skin Rejuvenation: Say goodbye to dull and tired skin! Antharidin Powder promotes skin rejuvenation by stimulating collagen production and enhancing skin elasticity. Experience a visibly smoother and firmer complexion, giving you a youthful and radiant glow.
3. Blemish-Free Beauty: Tired of battling blemishes and imperfections? Antharidin Powder is your ally in achieving blemish-free beauty. Its anti-inflammatory and antibacterial properties work together to combat acne, reduce redness, and promote clear, even-toned skin.
4. Natural Exfoliation: Unveil a fresh layer of skin with Antharidin Powder’s natural exfoliating properties. Bid farewell to dead skin cells and welcome a brighter complexion as this gentle exfoliant works its magic, leaving your skin feeling soft, supple, and revitalized.
5. Versatile Application: Antharidin Powder is incredibly versatile and can be easily incorporated into your existing skincare routine. Mix it with your favorite moisturizer, serum, or face mask for a customized skincare experience tailored to your unique needs.
6. Ethically Sourced: We take pride in our commitment to ethical sourcing practices. Our Antharidin Powder is responsibly harvested to ensure sustainability and environmental consciousness, allowing you to indulge in a skincare ritual that aligns with your values.

Antharidin Safety Tips

Handling of Antharidin should only be performed by personnel trained and familiar with handling of potent active pharmaceutical ingredients. Moderate to severe irritant to the skin and eyes.

References

• 1. Cantharidin as an Antitumor Agent: A Retrospective Review.
  Deng LP, Dong J, Cai H, Wang W.Curr Med Chem. 2012 Nov 26. [Epub ahead of print]
• 2. Clinical study on safety and efficacy of qinin® (cantharidin sodium) injection combined with chemotherapy in treating patients with gastric cancer.
  Zhan YP, Huang XE, Cao J, Lu YY, Wu XY, Liu J, Xu X, Xu L, Xiang J, Ye LH.Asian Pac J Cancer Prev. 2012;13(9):4773-6.
• 3. Adjunctive trichloroacetic Acid therapy enhances squaric Acid response to verruca vulgaris.
  Silverberg JI, Silverberg NB.J Drugs Dermatol. 2012 Oct 1;11(10):1228-30.
• 4. Norcantharidin suppresses cell growth and migration with enhanced anticancer activity of gefitinib and cisplatin in human non-small cell lung cancer cells.
  Lee YC, Lee LM, Yang CH, Lin AM, Huang YC, Hsu CC, Chen MS, Chi CW, Yin PH, Kuo CD, Liao JF, Lee HC.Oncol Rep. 2013 Jan;29(1):237-43. doi: 10.3892/or.2012.2118. Epub 2012 Oct 31.
• 5. Signaling events during cyclic guanosine monophosphate-regulated pigment aggregation in freshwater shrimp chromatophores.
  Milograna SR, Bell FT, McNamara JC.Biol Bull. 2012 Oct;223(2):178-91.
• 6. Quantitative microtiter fibronectin fibrillogenesis assay: use in high throughput screening for identification of inhibitor compounds.
  Tomasini-Johansson BR, Johnson IA, Hoffmann FM, Mosher DF.Matrix Biol. 2012 Jul;31(6):360-7. doi: 10.1016/j.matbio.2012.07.003. Epub 2012 Aug 6.
• 7. Norcantharidin facilitates LPS-mediated immune responses by up-regulation of AKT/NF-κB signaling in macrophages.
  Zhao Q, Qian Y, Li R, Tan B, Han H, Liu M, Qian M, Du B.PLoS One. 2012;7(9):e44956. doi: 10.1371/journal.pone.0044956. Epub 2012 Sep 11.
• 8. Topical treatments for cutaneous warts.
  Kwok CS, Gibbs S, Bennett C, Holland R, Abbott R.Cochrane Database Syst Rev. 2012 Sep 12;9:CD001781. doi: 10.1002/14651858.CD001781.pub3. Review.
• 9. Induction of apoptosis in human Hep3B hepatoma cells by norcantharidin through a p53 independent pathway via TRAIL/DR5 signal transduction.
  Yeh CH, Yang YY, Huang YF, Chow KC, Chen MF.Chin J Integr Med. 2012 Sep;18(9):676-82. doi: 10.1007/s11655-012-1206-8. Epub 2012 Aug 31.
• 10. Comparative gene expression profiling of benign and malignant lesions reveals candidate therapeutic compounds for leiomyosarcoma.
  Edris B, Fletcher JA, West RB, van de Rijn M, Beck AH.Sarcoma. 2012;2012:805614. doi: 10.1155/2012/805614. Epub 2012 Aug 5.
• 11. Cantharidin for the Treatment of Molluscum Contagiosum: A Prospective, Double-Blinded, Placebo-Controlled Trial.
  Coloe Dosal J, Stewart PW, Lin JA, Williams CS, Morrell DS.Pediatr Dermatol. 2012 Aug 16. doi: 10.1111/j.1525-1470.2012.01810.x. [Epub ahead of print]
• 12. Tropical dermatology: Venomous arthropods and human skin: Part I. Insecta.
  Haddad V Jr, Cardoso JL, Lupi O, Tyring SK.J Am Acad Dermatol. 2012 Sep;67(3):331.e1-14; quiz 345. doi: 10.1016/j.jaad.2012.04.048. Review.
• 13. Norcantharidin enhances bortezomib-antimyeloma activity in multiple myeloma cells in vitro and in nude mouse xenografts.
  Du HF, Yu LJ, Meng YF, Lv HY, Meng J, Song XN, Zhang JQ.Leuk Lymphoma. 2012 Sep 3. [Epub ahead of print]
• 14. Synthesis and anticancer activity of a series of norcantharidin analogues.
  Tarleton M, Gilbert J, Sakoff JA, McCluskey A.Eur J Med Chem. 2012 Aug;54:573-81. doi: 10.1016/j.ejmech.2012.06.010. Epub 2012 Jun 15.
• 15. Norcantharidin Induces HL-60 Cells Apoptosis In Vitro.
  Jiang YM, Meng ZZ, Yue GX, Chen JX.Evid Based Complement Alternat Med. 2012;2012:154271. doi: 10.1155/2012/154271. Epub 2012 Jun 24.
• 16. Cantharidin-induced inflammation in mouse ear model for translational research of novel anti-inflammatories.
  Ivetic Tkalcevic V, Hrvacic B, Bosnar M, Cuzic S, Bosnjak B, Erakovic Haber V, Glojnaric I.Transl Res. 2012 Aug;160(2):137-45. doi: 10.1016/j.trsl.2012.02.001. Epub 2012 Feb 25.
• 17. A protein phosphatase 2A catalytic subunit modulates blue light-induced chloroplast avoidance movements through regulating actin cytoskeleton in Arabidopsis.
  Wen F, Wang J, Xing D.Plant Cell Physiol. 2012 Aug;53(8):1366-79. doi: 10.1093/pcp/pcs081. Epub 2012 May 28.
• 18. Scutellaria baicalensis alleviates cantharidin-induced rat hemorrhagic cystitis through inhibition of cyclooxygenase-2 overexpression.
  Huan SK, Wang KT, Yeh SD, Lee CJ, Lin LC, Liu DZ, Wang CC.Molecules. 2012 May 25;17(6):6277-89. doi: 10.3390/molecules17066277.
• 19. Effect of norcantharidin on the human breast cancer bcap-37 cells.
  Liu D, Shi P, Yin X, Chen Z, Zhang X.Connect Tissue Res. 2012;53(6):508-12. doi: 10.3109/03008207.2012.694928. Epub 2012 Jul 20.
• 20. A Review for Mini-Review in Medicinal Chemistry.
  Deng L, Tang S, Qian Q.Mini Rev Med Chem. 2012 Apr 17. [Epub ahead of print]

Details